Continuation Rates of Self-administered Subcutaneous Depot Medroxyprogesterone Acetate and Provider-administered Intramuscular Depot Medroxyprogesterone Acetate in Patients Seeking Post-abortion Contraception
Latest Information Update: 01 Apr 2024
At a glance
- Drugs Medroxyprogesterone (Primary) ; Medroxyprogesterone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
Most Recent Events
- 01 Apr 2024 Planned End Date changed from 1 Oct 2023 to 1 Apr 2024.
- 25 Mar 2024 Planned primary completion date changed from 1 Oct 2023 to 1 Apr 2024.
- 18 Feb 2023 Status changed from not yet recruiting to recruiting.